Regarding adiponectin, only one patient had a lower level than the cut-off value for metabolic syndrome (4 μg/mL)20, and 184 patients (83.2%) had higher levels than the upper reference range for the healthy population (10 μg/mL)21. This evidence concerns the gene ADIPOQ and metabolic syndrome.